[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611867":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":11,"centralContacts":33,"locations":39,"responsibleParty":55,"collaborators":11,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":11,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":42,"whyStopped":11,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Lallemand Health Solutions","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1","EXPERIMENTAL",null,[13],"Other: Probiotic Formula 1",{"label":15,"type":10,"description":11,"interventionNames":16},"Group 2",[17],"Other: Probiotic Formula 2",{"label":19,"type":10,"description":11,"interventionNames":20},"Group 3",[21],"Other: Probiotic Formula 3",[23,27,30],{"type":24,"name":25,"description":25,"armGroupLabels":26,"otherNames":11},"OTHER","Probiotic Formula 1",[9],{"type":24,"name":28,"description":28,"armGroupLabels":29,"otherNames":11},"Probiotic Formula 2",[15],{"type":24,"name":31,"description":31,"armGroupLabels":32,"otherNames":11},"Probiotic Formula 3",[19],[34],{"name":35,"role":36,"phone":37,"phoneExt":11,"email":38},"Jenna Bouassaly, MSc","CONTACT","514-223-2057","jbouassaly@lallemand.com",[40],{"facility":41,"status":42,"city":43,"state":11,"zip":11,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Evalulab","RECRUITING","Montreal","Canada","CA",{"type":47,"coordinates":48},"Point",[49,50],-73.58781,45.50884,{"lat":50,"lon":49},[53],{"name":41,"role":36,"phone":54,"phoneExt":11,"email":11},"514-434-0001",{"type":56,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100611867","phase-2-vaginal-detection-of-orally-delivered-probiotic-strains-in-healthy-women-100611867",false,"NCT07246161","Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women","Detection of Orally Delivered Probiotic Strains in the Vaginal Microbiome of Healthy Female Adults","VSS2","Inclusion Criteria:\n\n* Clinically healthy female between the ages of 18 and 50 years, inclusive,\n* have a regular or predictable menstrual cycle\n* Typically have regular bowel movements,\n* Willing and able to consume a probiotic supplement for 4 weeks,\n* Willing to discontinue consumption of probiotic supplement and probiotic-fortified products 2 weeks before the start of the study and throughout the study,\n* Willing to discontinue fiber supplements 2 weeks before the start of the study, and throughout the study,\n* Willing to provide 1 stool sample 4 times throughout the study,\n* Willing to provide 2 vaginal swabs 4 times throughout the study,\n* Willing to undergo vaginal pH swab measurements (with a swab) 5 times throughout the study,\n* Willing to provide 2 perineal skin swabs (skin between the vagina and the anus) 3 times throughout the study,\n* Willing to complete a pregnancy test at the screening visit.\n\nExclusion Criteria:\n\n* Menopausal women,\n* Vaginal pH \\\u003C 2 or \\> 5 measured at screening,\n\n  •. Menstruation during the sample collection times,\n* Women that are lactating, pregnant, attempting to get pregnant, or have a positive pregnancy test,\n* Use of vaginal probiotics in the last 3 months,\n* Use of local vaginal antibiotics or antifungals in the last 3 months.\n* Use of oral antibiotics or antifungals in the last month,\n* Ongoing symptoms of vaginal and\u002For urinary tract infections,\n* Current treatment for vaginal sepsis or urosepsis,\n* Currently being treated for a severe chronic disease (e.g. cancer, renal failure, chronic inflammatory digestive or gastro-intestinal disease, immunodeficiency, etc.),\n* Clinical diagnosis of a gynecological disease or condition (e.g, fibroma, endometriosis, polycystic ovarian syndrome, etc.),\n* Clinical diagnosis of secondary dysmenorrhea,\n* Intolerance, allergy or sensitivity to milk, soy, or yeast.",true,"FEMALE","18 Years","50 Years",{"count":70,"type":71},72,"ESTIMATED","INTERVENTIONAL",[74],"PHASE2","The purpose of the present study is to obtain more information on the transit of orally ingested probiotics to the vagina.",[77],"Focus is on Healthy Subjects",[79,80],"Probiotics","Women's Health","2026-06-16",{"date":83,"type":84},"2026-06-18","ACTUAL",{"date":86,"type":84},"2025-10-20",{"date":88,"type":71},"2026-10",{"name":5,"class":6},1]